Detalhes bibliográficos
| Resumo: | Regulatory approaches for evaluating therapeutic equivalence of multisource (or generic) drug products vary among different countries and/or regions. Harmonization of these approaches may decrease the number of in vivo bioequivalence studies and avoid unnecessary drug exposure to humans. Global harmonization for regulatory requirements may be promoted by a better understanding of factors underlying product performance and expectations from different regulatory authorities. This workshop provided an opportunity for pharmaceutical scientists from academia, industry and regulatory agencies to have open discussions on current regulatory issues and industry practices, facilitating harmonization of regulatory approaches for establishing therapeutic equivalence and interchangeability of multisource drug products. |
|---|
| Autores principais: | Chen, Mei-Ling |
|---|
| Outros Autores: | Shah, Vinod P.; Crommelin, Daan J.; Shargel, Leon; Bashaw, Dennis; Bhatti, Masood; Blume, Henning; Dressman, Jennifer; Ducharme, Murray; Fackler, Paul; Hyslop, Terry; Lutter, Lorelei; Morais, José A. G.; Ormsby, Eric; Thomas, Saji; Tsang, Yu Chung; Velagapudi, Raja; Yu, Lawrence X. |
|---|
| Assunto: | Harmonization Interchangeability Regulatory standards Bioequivalence Therapeutic equivalence Biopharmaceutics classification system |
|---|
| Ano: | 2011 |
|---|
| País: | Portugal |
|---|
| Tipo de documento: | artigo |
|---|
| Tipo de acesso: | acesso restrito |
|---|
| Instituição associada: | Universidade de Lisboa |
|---|
| Idioma: | inglês |
|---|
| Origem: | Repositório da Universidade de Lisboa |
|---|